Acetyl-L-Carnitine Liquid
Natural health product licensed in Canada
- Licence holder
- Innovite
- NPN or DIN-HM
- 80042763
- Status
- Inactive licence
- Licence date
- 11 June 2013
- Revision date
- Not provided
- Form
- Liquides
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| L-Carnitine Source : Levocarnitine | 750 mg | Not calculated |
Non-medicinal ingredients
Feuille de Stevia rebaudiana, Eau purifiée, Saveur de punch aux fruits, Citrate de sodium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Cuillière(s) à table | 1 Tous les jours |
Uses authorised in Canada
Helps to maintain proper muscle function. Helps the body to metabolize fats.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
May cause gastrointestinal upset in which case discontinue use. Mild gastrointestinal symptoms (transient nause, vomiting, abdonimal cramps and diarrhoea) have been reported. Low incidences of seizures have been reported with oral doses in individuals with or without pre-existing seizure disorders.
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are pregnant or breastfeeding. Consult a health care practitioner prior to use if you have liver or kidney disease or if you have been instructed to follow a low protein diet. If you have been diagnosed and are being treated for primary systemic L-Carnitine deficiency or secondary L-Carnitine defiency, consult a health care practitioner. If you are taking any prescription medication, have a serious disease, or have a pre-existing seizure disorder; consult a health care practitioner prior to use.
Source
Official Health Canada record, licence 80042763
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.